chlorhexidine has been researched along with Encapsulating Peritoneal Sclerosis in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (5.00) | 29.6817 |
| 2010's | 30 (75.00) | 24.3611 |
| 2020's | 8 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Inoue, H; Koji, T; Mukae, H; Muta, K; Nishino, T; Obata, Y; Suzuki, C; Suzuki, T; Torigoe, K; Torigoe, M | 1 |
| Chang, MY; Chen, LH; Chiou, YY; Gao, J; Hung, SY; Lee, YC; Wang, HH | 1 |
| Chen, H; Chen, S; Hu, Y; Li, J; Liu, N; Lv, Z; Qiu, A; Shi, Y; Tang, L; Tao, M; Zhou, X | 1 |
| Hitomi, K; Ikeno, M; Ishimoto, T; Ito, Y; Kariya, T; Kinashi, H; Kunoki, S; Mizuno, M; Sakai, Y; Sasakura, H; Suzuki, Y; Takeuchi, K; Tatsukawa, H; Yamaguchi, M | 1 |
| Aten, J; Goldschmeding, R; Ito, Y; Katsuno, T; Kinashi, H; Maruyama, S; Mizuno, M; Nguyen, TQ; Sun, T; Suzuki, Y; Toda, N; Yanagita, M; Yokoi, H | 1 |
| Liu, N; Shao, X; Sharif, S; Xiong, C; Zhuang, S; Zou, H | 1 |
| Liang, YM; Liu, KH; OuYang, SX; Yang, YY; Zhou, N; Zou, Y | 1 |
| He, L; Huang, C; Liu, A; Song, Q; Sun, S; Xu, G; Zhao, L; Zheng, Y; Zhou, M | 1 |
| Bal, AZ; Duranay, M; Eser, EP; Karaköse, S | 1 |
| Da, J; Dong, R; Shen, Y; Yang, Y; Zha, Y | 1 |
| Furuichi, K; Hara, A; Iwata, Y; Kamikawa, Y; Kaneko, S; Kitajima, S; Miyagawa, T; Miyake, T; Nakagawa, S; Ogura, H; Oshima, M; Sagara, A; Sakai, N; Sato, K; Shimizu, M; Shinozaki, Y; Tamai, A; Toyama, T; Wada, T; Yamamura, Y | 1 |
| Do, JY; Heo, JY; Kang, SH; Kim, AY; Kim, SW; Lho, Y | 1 |
| Bilici, M; Borazan, A; Oz, II; Uygun Ilikhan, S | 1 |
| Furuichi, K; Hara, A; Iwata, Y; Kamikawa, Y; Kaneko, S; Kitajima, S; Lipson, KE; Miyake, T; Nakamura, M; Sagara, A; Sakai, N; Shimizu, M; Shinozaki, Y; Tager, AM; Toyama, T; Wada, T | 1 |
| Akutagawa, T; Aoki, S; Masuda, M; Morito, S; Nagase, K; Oshikata-Mitazaki, A; Sakumoto, T; Takezawa, T; Toda, S; Yamamoto-Rikitake, M | 1 |
| Cho, KS; Jeong, KH; Kim, JS; Lee, JH; Lee, SH; Lee, TW; Park, SH | 1 |
| Chen, N; Lin, T; Ren, H; Wang, W; Xie, J; Xu, T | 1 |
| Arikan, H; Asicioglu, E; Filinte, D; Kaya, H; Koc, M; Ozener, C; Tuglular, S; Tugtepe, H; Velioglu, A; Yilmaz, N | 1 |
| Doi, S; Doi, T; Higashi, Y; Honda, K; Kato, Y; Kawamoto, T; Kohno, N; Masaki, T; Nakashima, A; Ueno, T; Yokoyama, Y; Yorioka, N | 1 |
| Hattori, R; Imai, E; Ito, Y; Kinashi, H; Maruyama, S; Matsukawa, Y; Matsuo, S; Mizuno, M; Mizuno, T; Nagura, F; Nishimura, H; Nishio, R; Noda, Y; Suzuki, Y; Takei, Y; Terabayashi, T | 1 |
| Hsu, BG; Lee, CJ; Lee, RP; Liou, HH; Subeq, YM | 1 |
| Hamada, C; Horikoshi, S; Io, H; Kanda, R; Nakano, T; Tomino, Y; Wakabayashi, K | 1 |
| Ahn, JS; Cho, JH; Choi, JY; Kim, CD; Kim, KH; Kim, YL; Lee, JH; Oh, EJ; Oh, SH; Park, SH; Ryu, HM | 1 |
| Abe, S; Kitamura, M; Kohno, S; Koji, T; Muta, K; Nishino, T; Obata, Y; Oka, S; Ozono, Y | 1 |
| Ojima, M; Takahashi, S; Yoh, K | 1 |
| Ada, S; Camsari, T; Ersan, S; Kolatan, E; Sarioglu, S; Sert, M; Sifil, A; Unlu, M; Yilmaz, O | 1 |
| Chang, MY; Chen, CI; Chen, HC; Chen, HP; Chen, YT; Chiou, YY; Ho, LC; Hung, SY; Lee, YC; Lin, CW; Lin, SH; Lin, TM; Liou, HH; Liu, KW; She, KM; Tsai, CH; Tsai, YS; Wang, HH; Wang, HK; Wu, CF | 1 |
| Asahina, K; Li, Y; Lua, I; Pappoe, LS | 1 |
| Ahn, C; Cho, EJ; Hwang, YH; Ju, KD; Kim, HJ; Kim, K; Lee, J; Oh, KH; Ryu, H; Tsogbadrakh, B; Yang, J | 1 |
| Aslan, A; Borazan, A; Koseoglu, Z; Ozkan, OV; Yildirim, A | 1 |
| Ito, Y; Kato, S; Kurata, K; Maruyama, S; Matsuo, S; Mizuno, M; Morita, Y; Nabeshima, T; Nitta, A; Ozaki, T; Sato, W; Yamamoto, J; Yuzawa, Y | 1 |
| Hsu, BG; Ke, CY; Lee, CC; Lee, CJ; Lee, RP; Subeq, YM | 1 |
| de Graaff, M; Krediet, RT; Sampimon, DE; Struijk, DG; Vlijm, A | 1 |
| Chiu, YH; Hsu, BG; Ke, CY; Lee, CJ; Lin, NT; Subeq, YM | 1 |
| Higashi, K; Kumagai, H; Kushiyama, T; Miura, S; Oda, T; Oshima, N; Sakurai, Y; Yamada, M; Yamamoto, K | 1 |
| Fujimura, K; Hara, Y; Hasegawa, K; Hayashi, K; Homma, K; Hosoya, K; Itoh, H; Minakuchi, H; Tokuyama, H; Tonozuka, Y; Wakino, S; Washida, N | 1 |
| Akcicek, F; Bozkurt, D; Duman, S; Ertilav, M; Hur, E; Sarsik, B; Sipahi, S; Timur, O | 1 |
| Imamaki, H; Ishii, A; Kasahara, M; Kato, Y; Kawanishi, T; Koga, K; Kuwabara, T; Mori, K; Mori, KP; Mukoyama, M; Muramatsu, H; Muramatsu, T; Nakao, K; Ogawa, Y; Ohno, S; Sugawara, A; Toda, N; Yokoi, H | 1 |
| Akbal, E; Can, M; Ceri, M; Dogan, M; Duranay, M; Karaca, G; Kocak, G; Kurultak, I; Unverdi, H; Unverdi, S | 1 |
| Chun, J; Duffield, JS; Luster, AD; Sakai, N; Tager, AM; Wada, T | 1 |
40 other study(ies) available for chlorhexidine and Encapsulating Peritoneal Sclerosis
| Article | Year |
|---|---|
Mitochonic acid-5 ameliorates chlorhexidine gluconate-induced peritoneal fibrosis in mice.
Topics: Animals; Chlorhexidine; Disease Models, Animal; Indoleacetic Acids; Mice; Mice, Inbred C57BL; Peritoneal Fibrosis; Peritoneum; Phenylbutyrates | 2022 |
A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage.
Topics: Animals; Chlorhexidine; Disease Models, Animal; Humans; Male; Mice; Mice, Inbred C57BL; Peritoneal Fibrosis; Peritoneum; Renal Dialysis | 2022 |
Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization.
Topics: Chlorhexidine; Dialysis Solutions; Histone Deacetylase 6; Humans; Interleukin-4; Macrophages; Peritoneal Fibrosis; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Transforming Growth Factor beta | 2022 |
Inhibition of Transglutaminase 2 Reduces Peritoneal Injury in a Chlorhexidine-Induced Peritoneal Fibrosis Model.
Topics: Actins; Animals; Chlorhexidine; Endothelial Cells; Fibrosis; Inflammation; Mice; Mice, Knockout; Peritoneal Fibrosis; Peritoneum; Protein Glutamine gamma Glutamyltransferase 2; Rats; Transforming Growth Factor beta; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2023 |
Connective tissue growth factor is correlated with peritoneal lymphangiogenesis.
Topics: Animals; Cell Line; Chlorhexidine; Connective Tissue Growth Factor; Disease Models, Animal; Humans; Lymphangiogenesis; Lymphatic Vessels; Male; Mice; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Rats; Rats, Sprague-Dawley; RNA Interference; RNA, Small Interfering; Transforming Growth Factor beta1; Up-Regulation; Vascular Endothelial Growth Factor C | 2019 |
Delayed administration of suramin attenuates peritoneal fibrosis in rats.
Topics: Actins; Animals; Antineoplastic Agents; Chemokine CCL2; Chlorhexidine; Collagen Type I; ErbB Receptors; Fibronectins; Interleukin-1; Interleukin-6; Male; MAP Kinase Signaling System; Peritoneal Fibrosis; Peritoneum; Random Allocation; Rats; Rats, Sprague-Dawley; Smad3 Protein; STAT3 Transcription Factor; Suramin; Time Factors; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2019 |
Spleen Tyrosine Kinase (SYK) in the Progression of Peritoneal Fibrosis Through Activation of the TGF-β1/Smad3 Signaling Pathway.
Topics: Animals; China; Chlorhexidine; Disease Models, Animal; Disease Progression; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad3 Protein; Syk Kinase; Transforming Growth Factor beta1 | 2019 |
Expression of XBP1s in peritoneal mesothelial cells is critical for inflammation-induced peritoneal fibrosis.
Topics: Animals; Cell Line; Chlorhexidine; Epithelium; Humans; Inflammation; Inflammation Mediators; Interleukin-1beta; Male; Neovascularization, Pathologic; Peritoneal Fibrosis; Peritoneum; Rats, Sprague-Dawley; X-Box Binding Protein 1 | 2019 |
The effect of rituximab on encapsulated peritoneal sclerosis in an experimental rat model
Topics: Animals; Biomarkers; Chlorhexidine; Disease Models, Animal; Female; Peritoneal Fibrosis; Rats; Rats, Wistar; Rituximab; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2020 |
Therapeutic effect of 1,25(OH)2-VitaminD3 on fibrosis and angiogenesis of peritoneum induced by chlorhexidine.
Topics: Animals; Antigens, CD34; Calcitriol; Cells, Cultured; Chlorhexidine; Connective Tissue Growth Factor; Disease Models, Animal; Fibrosis; HSP47 Heat-Shock Proteins; Male; Neovascularization, Pathologic; Peritoneal Fibrosis; Peritoneum; Rats, Sprague-Dawley; Signal Transduction; Vascular Endothelial Growth Factor A | 2020 |
Trehalose ameliorates peritoneal fibrosis by promoting Snail degradation and inhibiting mesothelial-to-mesenchymal transition in mesothelial cells.
Topics: Animals; Chlorhexidine; Epithelial Cells; Epithelial-Mesenchymal Transition; Male; Mice; Mice, Inbred C57BL; Myofibroblasts; Peritoneal Fibrosis; Snail Family Transcription Factors; Trehalose | 2020 |
Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.
Topics: Animals; Benzamides; Cell Movement; Cells, Cultured; Chlorhexidine; Collagen; Disease Models, Animal; Epithelial Cells; Epithelial-Mesenchymal Transition; Humans; Male; Mice; Mice, Inbred C57BL; Peritoneal Fibrosis; Peritoneum; Phosphorylation; Protein Processing, Post-Translational; Pyrazoles; Receptor, Transforming Growth Factor-beta Type I; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2021 |
Effects of Erythropoiesis-stimulating Agents on Intestinal Flora in Peritoneal Fibrosis.
Topics: Animals; Bacteria; Chlorhexidine; Disease Models, Animal; Erythropoietin; Female; Gastrointestinal Microbiome; Hematinics; Intestines; Peristalsis; Peritoneal Fibrosis; Rats, Wistar; Recombinant Proteins | 2017 |
Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Differentiation; Chlorhexidine; Collagen Type I; Connective Tissue Growth Factor; Disease Models, Animal; Fibroblasts; Gene Expression Regulation; Genes, Reporter; Green Fluorescent Proteins; Humans; Mice; Mice, Transgenic; Myofibroblasts; Neovascularization, Pathologic; NIH 3T3 Cells; Peritoneal Fibrosis; Signal Transduction; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2017 |
A high-density collagen xerogel thread prevents the progression of peritoneal fibrosis.
Topics: Animals; Chlorhexidine; Collagen; Disease Models, Animal; Disease Progression; Female; Gels; Mice, Inbred ICR; Peritoneal Fibrosis | 2018 |
Itraconazole Attenuates Peritoneal Fibrosis Through Its Effect on the Sonic Hedgehog Signaling Pathway in Mice.
Topics: Animals; Chlorhexidine; Disease Models, Animal; Hedgehog Proteins; Humans; Injections, Intraperitoneal; Itraconazole; Male; Mice; Mice, Inbred C57BL; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Signal Transduction; Treatment Outcome | 2018 |
Comparison of anti-peritoneal fibrotic effects between an mTORC1-specific blocker and a PI3K/mTOR dual-blocker.
Topics: Animals; Chlorhexidine; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Imidazoles; Injections, Intraperitoneal; Kidney Failure, Chronic; Male; Mechanistic Target of Rapamycin Complex 1; Peritoneal Dialysis; Peritoneal Fibrosis; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinolines; Rats; Rats, Sprague-Dawley; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2019 |
Role of tyrosine kinase inhibition with imatinib in an encapsulating peritoneal sclerosis rat model.
Topics: Animals; Benzamides; Chlorhexidine; Disease Models, Animal; Imatinib Mesylate; Immunohistochemistry; Male; Peritoneal Fibrosis; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Wistar; Transforming Growth Factor beta1 | 2013 |
Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling.
Topics: Animals; Animals, Genetically Modified; Cells, Cultured; Chemotaxis; Chlorhexidine; Coculture Techniques; Culture Media, Conditioned; Disease Models, Animal; Epithelial-Mesenchymal Transition; Extracellular Matrix Proteins; Glucose; Green Fluorescent Proteins; Hepatocyte Growth Factor; Humans; Inflammation Mediators; Macrophages; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Paracrine Communication; Peritoneal Fibrosis; Peritoneum; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Signal Transduction; Smad2 Protein; Time Factors; Transforming Growth Factor beta1 | 2013 |
TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Cell Line; Chlorhexidine; Female; Humans; Hyaluronan Receptors; Lymphangiogenesis; Lymphatic Vessels; Male; Membrane Glycoproteins; Middle Aged; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Up-Regulation; Vascular Endothelial Growth Factor C | 2013 |
Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Topics: Angiotensin II; Animals; Calcitriol; Chlorhexidine; Dialysis Solutions; Liver; Male; Muscles; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1 | 2014 |
Adipose-derived mesenchymal stem cells transplantation facilitate experimental peritoneal fibrosis repair by suppressing epithelial-mesenchymal transition.
Topics: Animals; Cell Differentiation; Cells, Cultured; Chlorhexidine; Disease Models, Animal; Epithelial-Mesenchymal Transition; Gene Expression Regulation; Injections, Intraperitoneal; Male; Mesenchymal Stem Cell Transplantation; Neovascularization, Physiologic; Peritoneal Fibrosis; Peritoneum; Rats, Sprague-Dawley; Rats, Transgenic; RNA, Messenger; Subcutaneous Fat; Time Factors | 2014 |
Effect of DNA demethylation in experimental encapsulating peritoneal sclerosis.
Topics: Animals; Azacitidine; Chlorhexidine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Ethanol; Gene Expression Regulation; Male; Peritoneal Dialysis; Peritoneal Fibrosis; ras GTPase-Activating Proteins; Rats; Rats, Sprague-Dawley | 2014 |
The kampo medicine Daikenchuto inhibits peritoneal fibrosis in mice.
Topics: Actins; Animals; Antigens, Differentiation; Chemokine CCL2; Chlorhexidine; HSP47 Heat-Shock Proteins; Male; Medicine, Kampo; Mice, Inbred ICR; Panax; Peritoneal Fibrosis; Peritoneum; Phytotherapy; Plant Extracts; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Zanthoxylum; Zingiberaceae | 2015 |
Th2-biased GATA-3 transgenic mice developed severe experimental peritoneal fibrosis compared with Th1-biased T-bet and Th17-biased RORγt transgenic mice.
Topics: Animals; Ascitic Fluid; Chlorhexidine; Disease Progression; GATA3 Transcription Factor; Interferon-gamma; Interleukin-13; Mice, Transgenic; Nuclear Receptor Subfamily 1, Group F, Member 3; Peritoneal Dialysis; Peritoneal Fibrosis; Severity of Illness Index; T-Box Domain Proteins; T-Lymphocytes; Th1 Cells; Th17 Cells; Th2 Cells | 2015 |
Effect of bevacizumab, a vascular endothelial growth factor inhibitor, on a rat model of peritoneal sclerosis.
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Chlorhexidine; Disease Models, Animal; Female; Neovascularization, Pathologic; Peritoneal Fibrosis; Peritoneum; Rats; Rats, Wistar | 2015 |
Vitamin D can ameliorate chlorhexidine gluconate-induced peritoneal fibrosis and functional deterioration through the inhibition of epithelial-to-mesenchymal transition of mesothelial cells.
Topics: Animals; Cells, Cultured; Chlorhexidine; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Epithelium; Humans; Male; Peritoneal Fibrosis; Rats; Rats, Sprague-Dawley; Treatment Outcome; Vitamin D | 2015 |
Myofibroblastic Conversion and Regeneration of Mesothelial Cells in Peritoneal and Liver Fibrosis.
Topics: Animals; Cell Differentiation; Cells, Cultured; Chlorhexidine; Down-Regulation; Epithelial Cells; Gene Deletion; Gene Expression Regulation; Liver Cirrhosis; Mice, Transgenic; Myofibroblasts; Peritoneal Cavity; Peritoneal Fibrosis; Phenotype; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Regeneration; Transforming Growth Factor beta1 | 2015 |
HL156A, a novel AMP-activated protein kinase activator, is protective against peritoneal fibrosis in an in vivo and in vitro model of peritoneal fibrosis.
Topics: AMP-Activated Protein Kinases; Animals; Cell Transdifferentiation; Cells, Cultured; Chlorhexidine; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Epithelial-Mesenchymal Transition; Ethanol; Fibronectins; Glucose; Guanidines; Male; Myofibroblasts; Peritoneal Fibrosis; Peritoneum; Pyrrolidines; Rats, Wistar; RNA Interference; Smad3 Protein; Snail Family Transcription Factors; Transcription Factors; Transfection; Transforming Growth Factor beta1 | 2016 |
The effects of low-dose erythropoiesis-stimulating agents on peritoneal fibrosis induced by chemical peritonitis and on peritoneal tissue MMP-2 and TIMP-2 Levels in rats.
Topics: Analysis of Variance; Animals; Biomarkers; Chlorhexidine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hematinics; Immunohistochemistry; Injections, Intraperitoneal; Injections, Subcutaneous; Matrix Metalloproteinase 2; Peritoneal Fibrosis; Peritoneum; Peritonitis; Probability; Random Allocation; Rats; Rats, Wistar; Reference Values; Statistics, Nonparametric; Tissue Inhibitor of Metalloproteinase-1 | 2009 |
Tissue-type plasminogen activator deficiency attenuates peritoneal fibrosis in mice.
Topics: Animals; Chlorhexidine; Fibrinolysin; Immunohistochemistry; Matrix Metalloproteinase 2; Matrix Metalloproteinases; Metallothionein 3; Mice; Mice, Knockout; Peritoneal Fibrosis; Peritoneum; Phosphorylation; RNA, Messenger; Smad3 Protein; Tissue Plasminogen Activator; Transforming Growth Factor beta1 | 2009 |
Aliskiren ameliorates chlorhexidine digluconate-induced peritoneal fibrosis in rats.
Topics: Amides; Animals; Anti-Infective Agents; Chlorhexidine; Fumarates; Peritoneal Dialysis; Peritoneal Fibrosis; Rats; Rats, Sprague-Dawley; Renin; Transforming Growth Factor beta1; Treatment Outcome | 2010 |
Experimental peritoneal sclerosis models should not be based on chlorhexidine gluconate anymore.
Topics: Animals; Chlorhexidine; Dialysis Solutions; Disease Models, Animal; Kidney Failure, Chronic; Male; Nephrectomy; Peritoneal Dialysis; Peritoneal Fibrosis; Rats; Rats, Wistar | 2011 |
Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Topics: Animals; Blood Pressure; Chlorhexidine; Glucose; Heart Rate; Immunohistochemistry; Liver Cirrhosis; Male; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Protective Agents; Rats; Rats, Sprague-Dawley; Staining and Labeling; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan | 2011 |
Effects of liposome-encapsulated clodronate on chlorhexidine gluconate-induced peritoneal fibrosis in rats.
Topics: Animals; Anti-Infective Agents; Biomarkers; Blotting, Western; Bone Density Conservation Agents; Cells, Cultured; Chlorhexidine; Clodronic Acid; Immunoenzyme Techniques; Injections, Intraperitoneal; Liposomes; Macrophages, Peritoneal; Male; Neutrophils; Peritoneal Fibrosis; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta1 | 2011 |
Rho-kinase inhibition ameliorates peritoneal fibrosis and angiogenesis in a rat model of peritoneal sclerosis.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Anti-Infective Agents, Local; Cells, Cultured; Chlorhexidine; Disease Models, Animal; Enzyme Inhibitors; Epithelium; Humans; Immunoenzyme Techniques; Male; Neovascularization, Pathologic; Peritoneal Fibrosis; Pleural Cavity; Pyridines; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2011 |
Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Chemokine CCL2; Chlorhexidine; Dialysis Solutions; Disease Models, Animal; Fibrosis; Male; Neovascularization, Pathologic; Octreotide; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Permeability; Rats; Rats, Wistar; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2011 |
Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
Topics: Adult; Aged, 80 and over; Animals; Biopsy; Carrier Proteins; CD3 Complex; Cell Movement; Cells, Cultured; Chlorhexidine; Connective Tissue Growth Factor; Cytokines; Dialysis Solutions; Female; Fibronectins; Gene Expression; Humans; Interleukin-1beta; Ki-67 Antigen; Lymphocyte Count; Male; Mice; Middle Aged; Mitotic Index; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Peritonitis; Permeability; RNA, Messenger; T-Lymphocytes; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Up-Regulation | 2012 |
Effect of sirolimus on the regression of peritoneal sclerosis in an experimental rat model.
Topics: Animals; Chlorhexidine; Female; Immunosuppressive Agents; Matrix Metalloproteinase 2; Peritoneal Dialysis; Peritoneal Fibrosis; Rats; Rats, Wistar; Sirolimus; Statistics, Nonparametric | 2012 |
LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.
Topics: Anilides; Animals; Benzamides; Biphenyl Compounds; Cell Proliferation; Chlorhexidine; Connective Tissue Growth Factor; Cytoskeleton; Disease Models, Animal; Epithelial Cells; Epithelium; Isoxazoles; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Knockout; Myofibroblasts; Peritoneal Fibrosis; Receptors, Lysophosphatidic Acid; Trans-Activators; Transcription Factors | 2013 |